Speakers
Distinguished Panel and Speakers include:
- Dr Julianna Lisziewicz, CEO, Genetic Immunity, Hungary/USA
- Dr Nakissa Sadrieh, Associate Director for Research Policy and Implementation, Center for Drug Evaluation and Research, Food and Drug Administration, USA
- Professor Larry Sternson, President and CEO, Avidimer Therapeutics, and Research Professor of Internal Medicine, College of Medicine, University of Michigan, USA
- Dr Thomas Keller Director, Biophysical Sensors Nanomaterials, GlaxoSmithKline, UK
- David Owen, BSc(Hons) PhD, VP Research, Starpharma Pty Ltd, Australia
- Professor Ijeoma Uchegbu, Department of Pharmaceutics, School of Pharmacy, University of London, UK
- Dr Xiaodong Yang VP, Research and Preclinical Development, Intradigm, USA
- Dr Christof Fattinger, Head of Microtechnologies and Automation, Discovery Technologies, F. Hoffmann-La Roche, Switzerland
- Mr Stephen Maebius, Lead Attorney, Foley & Lardner, International Law Firm and Patent Agents, US
- Mr Mark Bünger Research Director, Lux Research, USA
- Dr Silke Krol, Senior Scientist and Head of the NanoBioMed Group, Laboratory for Nanodiagnostics, Drug Delivery and Analysis, The Center of Molecular Biomedicine (CBM), Italy
- Dr Rajagopal Ramesh, Associate Professor, MD Anderson Cancer Center, USA